Indivior (INDV) is a specialty pharmaceutical company headquartered in Richmond, Virginia, US. Its product portfolio includes Subutex and its Naloxone-combined preparation Suboxone. The business is also engaged in producing remedies for cocaine and opioid analgesic overdose, as well as a treatment for alcohol dependence. The Indivior share price is listed on the London Stock Exchange and included in the FTSE 250 Index. In 2018, the company’s annual revenue was more than $1 billion.
To discover the latest INDV share price, follow Capital.com.